Keppra

Levetiracetam, the active ingredient in Keppra, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy, helping to reduce the frequency and severity of seizures. It belongs to the class of antiepileptic drugs and is indicated for patients aged two years and older.

GNH USA supplies Keppra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including major hospital networks, independent pharmacies and specialized clinics across Europe, Asia and the Americas.

Levetiracetam (Keppra) is used to treat seizure disorders within the antiepileptic drug class.

Partial-onset seizures: reduces seizure frequency in patients with focal epilepsy. Generalized tonic-clonic seizures: helps control convulsive episodes in patients with generalized epilepsy. Myoclonic seizures: decreases the occurrence of rapid muscle jerks in appropriate patients.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: a sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or lacking energy. - Headache: mild to moderate pain in the head region. - Irritability: increased agitation or mood changes.

Serious or Rare Side Effects: - Severe allergic reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts or behavior: new or worsening depression, anxiety, or suicidal ideation. - Severe skin rash: widespread rash that may require medical attention. - Blood disorders: such as neutropenia or thrombocytopenia.

Before initiating levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose based on creatinine clearance. Hepatic impairment: monitor liver function tests. Psychiatric symptoms: monitor for mood changes, depression, or suicidal ideation. Pregnancy: discuss potential risks as safety data are limited. Driving and operating machinery: avoid until individual response is known. Store at ambient temperature: keep in original container, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: may reduce levetiracetam levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptics: may require dose adjustments. - Renal excretion inhibitors (e.g., probenecid): may increase levetiracetam levels.